You are here

elotuzumab

Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug

Fierce Biotech

Tue, 09/1/15 - 06:38 pm

Bristol-Myers Squibb

Multiple Myeloma

J&J positions blockbuster contender daratumumab for a multiple myeloma showdown

Fierce Biotech

Thu, 08/27/15 - 09:55 am

Multiple Myeloma

Bristol-Myers Squibb

Bristol, AbbVie drug extends multiple myeloma remission-study

Yahoo/Reuters

Thu, 05/14/15 - 09:56 am

Bristol-Myers Squibb

Multiple Myeloma

ASCO cancer research data drop: What to watch

CNBC

Wed, 05/13/15 - 12:18 pm

Bristol-Myers Squibb

Juno Therapeutics

Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab

The Fly on the Wall

Mon, 05/19/14 - 09:17 am

Bristol-Myers Squibb

Multiple Myeloma

Bristol-Myers Has The Future Of Oncology Therapies

Seeking Alpha

Sun, 05/5/13 - 11:00 am

Bristol-Myers Squibb

non-small cell lung cancer

renal cell carcinoma

Ono Pharmaceutical

Aveo Pharmaceuticals

Celgene's Star Drug Revlimid And Its Competitors

Seeking Alpha

Sat, 03/30/13 - 10:57 am

Multiple Myeloma

Bristol-Myers Squibb